What Does BCAT-IN-4 Mean?
MI-CP151 was a phase 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre study To guage various intravenous doses of sifalimumab, in Grownup individuals with dermatomyositis or polymyositis (NCT00533091). Primary demo aims had been To judge the safety and tolerability of sifalimumab in dermatomyositis or polymyositis suffe